/
/
/

Shukra Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)53.01
Volume (₹)7.30 L
High (₹)55.50
Upper Circuit62.40
Low (₹)51.78
Lower Circuit41.60
Prev Close52.00
52W High (₹)65.26
Price51.93
52W Low (₹)26.18

Share Market Cap & Key Ratios Overview

M.Cap (₹)2292.09 Cr
Div. Yield (%)0.02
PE Ratio63.59
Debt to Equity0.07
Price to Book15.23
Book Value1.44
EPS (TTM)0.82
Face Value1.00
ROE (%)15.90

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SHUKRAPHAR-BNSE
LTP
1W Low
1W High
Market cap (₹)
1901.5-18.6 (-0.97%)
1896.30
1964.85
4,56,833Cr
9151-118 (-1.27%)
9051.85
9296
2,45,426Cr
4837-198 (-3.93%)
4822.25
5049
1,87,320Cr
1129-58 (-4.89%)
1126
1191.45
1,13,217Cr
1380-38 (-2.68%)
1376
1426.20
1,12,212Cr
1845.9-89.4 (-4.62%)
1812
1947.90
1,01,155Cr
2111.5-63.5 (-2.92%)
2107.35
2209
97,626Cr
2333.1-54.3 (-2.27%)
2323.15
2407.40
96,859Cr
1158-19.8 (-1.68%)
1155
1179.90
96,406Cr
1651.9+1.9 (0.12%)
1623.05
1706.70
93,614Cr
51.93+7.65 (17.28%)
44.26
55.50
2,292Cr

Key Highlights of Shukra Pharmaceuticals Ltd Balance Sheet

Shukra Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹43.79Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹43.79Cr, and the reserves and surplus of the company is ₹19.05Cr.

The company has its non-current liabilities with total liabilities of ₹86.77Cr as of 2025-03-31.

The current liabilities are ₹17.28Cr as of 2025-03-31. At the same time, current assets are ₹65.43Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹19.4Cr, provided in the Shukra Pharmaceuticals Ltd financial statements.